kung hsiang fu - Search Results

Year	Number of Results
1992	1
2001	1
2002	12
2003	15
2004	14
2005	16
2006	22
2007	17
2008	26
2009	31
2010	36
2011	37
2012	22
2013	19
2014	12
2015	16
2016	9
2017	11
2018	8
2019	1
2020	1
2021	4
2024	0

1

Correction: Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets.

Zheng F, Liao YJ, Cai MY, Liu TH, Chen SP, Wu PH, Wu L, Bian XW, Guan XY, Zeng YX, Yuan YF, Kung HF, Xie D. Zheng F, et al. Among authors: kung hf. PLoS Genet. 2021 Dec 8;17(12):e1009960. doi: 10.1371/journal.pgen.1009960. eCollection 2021 Dec. PLoS Genet. 2021. PMID: 34879067 Free PMC article.

2

Corrigendum to "The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas" [Canc. Lett. 353 (2014) 104-114].

Tian XP, Qian D, He LR, Huang H, Mai SJ, Li CP, Huang XX, Cai MY, Liao YJ, Kung HF, Zeng YX, Xie D. Tian XP, et al. Among authors: kung hf. Cancer Lett. 2021 Oct 28;519:345. doi: 10.1016/j.canlet.2021.07.043. Epub 2021 Aug 3. Cancer Lett. 2021. PMID: 34353674 No abstract available.

3

Corrigendum to ‟The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas" [Canc. Lett. 353 (2014) 104-114].

Tian XP, Qian D, He LR, Huang H, Mai SJ, Li CP, Huang XX, Cai MY, Liao YJ, Kung HF, Zeng YX, Xie D. Tian XP, et al. Among authors: kung hf. Cancer Lett. 2021 Sep 28;516:61-63. doi: 10.1016/j.canlet.2021.05.023. Epub 2021 Jun 3. Cancer Lett. 2021. PMID: 34091434 No abstract available.

4

Correction to: FMNL1 mediates nasopharyngeal carcinoma cell aggressiveness by epigenetically upregulating MTA1.

Chen WH, Cai MY, Zhang JX, Wang FW, Tang LQ, Liao YJ, Jin XH, Wang CY, Guo L, Jiang YG, Ren CP, Mai HQ, Zeng MS, Kung HF, Qian CN, Xie D. Chen WH, et al. Among authors: kung hf. Oncogene. 2021 Apr;40(16):2998-3000. doi: 10.1038/s41388-021-01751-3. Oncogene. 2021. PMID: 33767442 No abstract available.

5

Pten-mediated Gsk3β modulates the naïve pluripotency maintenance in embryonic stem cells.

Wang W, Lu G, Su X, Tang C, Li H, Xiong Z, Leung CK, Wong MS, Liu H, Ma JL, Cheung HH, Kung HF, Chen ZJ, Chan WY. Wang W, et al. Among authors: kung hf. Cell Death Dis. 2020 Feb 7;11(2):107. doi: 10.1038/s41419-020-2271-0. Cell Death Dis. 2020. PMID: 32034125 Free PMC article.

6

The antipsychotic agent flupentixol is a new PI3K inhibitor and potential anticancer drug for lung cancer.

Dong C, Chen Y, Li H, Yang Y, Zhang H, Ke K, Shi XN, Liu X, Li L, Ma J, Kung HF, Chen C, Lin MC. Dong C, et al. Among authors: kung hf. Int J Biol Sci. 2019 Jun 2;15(7):1523-1532. doi: 10.7150/ijbs.32625. eCollection 2019. Int J Biol Sci. 2019. PMID: 31337981 Free PMC article.

7

Novel HDAC5-interacting motifs of Tbx3 are essential for the suppression of E-cadherin expression and for the promotion of metastasis in hepatocellular carcinoma.

Dong L, Dong Q, Chen Y, Li Y, Zhang B, Zhou F, Lyu X, Chen GG, Lai P, Kung HF, He ML. Dong L, et al. Among authors: kung hf. Signal Transduct Target Ther. 2018 Aug 24;3:22. doi: 10.1038/s41392-018-0025-6. eCollection 2018. Signal Transduct Target Ther. 2018. PMID: 30151243 Free PMC article.

8

FMNL1 mediates nasopharyngeal carcinoma cell aggressiveness by epigenetically upregulating MTA1.

Chen WH, Cai MY, Zhang JX, Wang FW, Tang LQ, Liao YJ, Jin XH, Wang CY, Guo L, Jiang YG, Ren CP, Mai HQ, Zeng MS, Kung HF, Qian CN, Xie D. Chen WH, et al. Among authors: kung hf. Oncogene. 2018 Nov;37(48):6243-6258. doi: 10.1038/s41388-018-0351-8. Epub 2018 Jul 16. Oncogene. 2018. PMID: 30013189

9

Discovery of rafoxanide as a dual CDK4/6 inhibitor for the treatment of skin cancer.

Shi X, Li H, Shi A, Yao H, Ke K, Dong C, Zhu Y, Qin Y, Ding Y, He YH, Liu X, Li L, Lei L, Hai Q, Chen W, Leung KS, Wong MH, Kung HF, Lin MC. Shi X, et al. Among authors: kung hf. Oncol Rep. 2018 Sep;40(3):1592-1600. doi: 10.3892/or.2018.6533. Epub 2018 Jun 27. Oncol Rep. 2018. PMID: 29956794

10

Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance.

Shi Y, Guryanova OA, Zhou W, Liu C, Huang Z, Fang X, Wang X, Chen C, Wu Q, He Z, Wang W, Zhang W, Jiang T, Liu Q, Chen Y, Wang W, Wu J, Kim L, Gimple RC, Feng H, Kung HF, Yu JS, Rich JN, Ping YF, Bian XW, Bao S. Shi Y, et al. Among authors: kung hf. Sci Transl Med. 2018 May 30;10(443):eaah6816. doi: 10.1126/scitranslmed.aah6816. Sci Transl Med. 2018. PMID: 29848664 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

287 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

287 results

Results by year